- Home
- ATHA vs DMN Comparison
ATHA vs DMN Comparison
Compare ATHA & DMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- DMN
- Stock Information
- Founded
- ATHA 2011
- DMN 2020
- Country
- ATHA United States
- DMN Canada
- Employees
- ATHA N/A
- DMN N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- DMN
- Sector
- ATHA Health Care
- DMN
- Exchange
- ATHA Nasdaq
- DMN NYSE
- Market Cap
- ATHA 21.0M
- DMN 19.4M
- IPO Year
- ATHA 2020
- DMN N/A
- Fundamental
- Price
- ATHA $0.53
- DMN $0.73
- Analyst Decision
- ATHA Buy
- DMN
- Analyst Count
- ATHA 4
- DMN 0
- Target Price
- ATHA $11.25
- DMN N/A
- AVG Volume (30 Days)
- ATHA 235.4K
- DMN 442.1K
- Earning Date
- ATHA 02-20-2025
- DMN 02-15-2025
- Dividend Yield
- ATHA N/A
- DMN N/A
- EPS Growth
- ATHA N/A
- DMN N/A
- EPS
- ATHA N/A
- DMN N/A
- Revenue
- ATHA N/A
- DMN N/A
- Revenue This Year
- ATHA N/A
- DMN N/A
- Revenue Next Year
- ATHA N/A
- DMN N/A
- P/E Ratio
- ATHA N/A
- DMN N/A
- Revenue Growth
- ATHA N/A
- DMN N/A
- 52 Week Low
- ATHA $0.41
- DMN $0.51
- 52 Week High
- ATHA $4.30
- DMN $4.95
- Technical
- Relative Strength Index (RSI)
- ATHA 41.88
- DMN N/A
- Support Level
- ATHA $0.52
- DMN N/A
- Resistance Level
- ATHA $0.57
- DMN N/A
- Average True Range (ATR)
- ATHA 0.04
- DMN 0.00
- MACD
- ATHA -0.00
- DMN 0.00
- Stochastic Oscillator
- ATHA 11.82
- DMN 0.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About DMN DAMON INC
Damon Inc is a motorcycle manufacturing company that aims to transform the motorcycle industry by building a smart and technologically advanced motorcycle. Damon is developing technology and investing in capabilities to lead the industry in the transformation of the high-performance electric motorcycle market. It is introducing existing enthusiasts to high-performance electric products while bringing new riders to the motorcycle community with first-of-its-kind advances in zero-emissions motorcycle performance, safety, connectivity and AI.